Checked
Ulcerative colitis Clinical Trials in Connecticut
Open studies with at least one site in the state
Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.
- Open studies
- 12
- With a site in Connecticut
- Most studies in
- New Haven
- 5 of the studies shown
Studies
12 of 12, recruiting studies first. Cities are where the study lists a Connecticut site.
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingPhase 3NCT07184996· Sanofi
New Haven
- A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative ColitisRecruitingPhase 2NCT07845487· Palisade Bio
Bristol
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruitingPhase 2, Phase 3NCT05076175· Bristol-Myers Squibb
Hartford
- LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisRecruitingPhase 2NCT07415044· Eli Lilly and Company
Hamden
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)RecruitingPhase 3NCT04844606· Eli Lilly and Company
Hartford
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingPhase 1NCT03816345· National Cancer Institute (NCI)
New Haven
- Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)RecruitingPhase 3NCT06651281· Merck Sharp & Dohme LLC
Bristol
- A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative ColitisRecruitingPhase 3NCT07196748· Janssen Research & Development, LLC
Danbury, Hartford
- Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic RemissionRecruitingNCT05230173· Mayo Clinic
New Haven
- Zymfentra (Infliximab-dyyb) REal World Cohort STudyRecruitingNCT07237516· University of North Carolina, Chapel Hill
New Haven
- Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBDRecruitingNCT07224113· Connecticut Children's Medical Center
Hartford
- Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseEnrolling by invitationNCT02791854· Dartmouth-Hitchcock Medical Center
New Haven
Other other conditions studies in Connecticut
Frequently asked questions
- Are there ulcerative colitis clinical trials in Connecticut?
- Yes. 12 ulcerative colitis studies on ClinicalTrials.gov list at least one site in Connecticut and are recruiting, about to recruit or enrolling by invitation, including sites in New Haven, Hartford, Bristol.
- What does recruiting mean?
- Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
- How do I join a clinical trial?
- Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.
Source: ClinicalTrials.gov, National Library of Medicine · Last updated 10/26/2026